Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

620 ARTÍCULOS , VIENDO DEL 271 AL 285

Effects of Body Weight on the Safety of High-Dose Donepezil in Alzheimer's Disease: Post hoc Analysis of a Multicenter, Randomized, Open-Label, Parallel Design, Three-Arm Clinical Trial

Hong YJ, Han HJ, Youn YC, Park KW, Yang DW, Kim S, Kim HJ, Kim HJ, Lee Y, Kwon M, Lee JH; ODESA study (Optimal Dose Escalation Strategy to Successful Achievement of High Dose Donepezil 23 mg).

Dement Geriatr Cogn Disord. 2021;50(3):289-295. doi: 10.1159/000518470. Epub 2021 Sep 10.

Neuroprotective potential of berberine in modulating Alzheimer's disease via multiple signaling pathways

Akbar M, Shabbir A, Rehman K, Akash MSH, Shah MA.

J Food Biochem. 2021 Oct;45(10):e13936. doi: 10.1111/jfbc.13936. Epub 2021 Sep 14.

The Beneficial Role of Natural Endocrine Disruptors: Phytoestrogens in Alzheimer's Disease

Domańska A, Orzechowski A, Litwiniuk A, Kalisz M, Bik W, Baranowska-Bik A.

Oxid Med Cell Longev. 2021 Sep 3;2021:3961445. doi: 10.1155/2021/3961445. eCollection 2021.

Cannabinoids for the treatment of dementia

Bosnjak Kuharic D, Markovic D, Brkovic T, Jeric Kegalj M, Rubic Z, Vuica Vukasovic A, Jeroncic A, Puljak L.

Cochrane Database Syst Rev. 2021 Sep 17;9(9):CD012820. doi: 10.1002/14651858.CD012820.pub2.

Can we learn lessons from the FDA's approval of aducanumab?

Liu KY, Howard R.

Nat Rev Neurol. 2021 Nov;17(11):715-722. doi: 10.1038/s41582-021-00557-x. Epub 2021 Sep 17.

The case for low-level BACE1 inhibition for the prevention of Alzheimer disease

McDade E, Voytyuk I, Aisen P, Bateman RJ, Carrillo MC, De Strooper B, Haass C, Reiman EM, Sperling R, Tariot PN, Yan R, Masters CL, Vassar R, Lichtenthaler SF.

Nat Rev Neurol. 2021 Nov;17(11):703-714. doi: 10.1038/s41582-021-00545-1. Epub 2021 Sep 21.

Autophagy in Alzheimer's disease pathogenesis: Therapeutic potential and future perspectives

Zhang Z, Yang X, Song YQ, Tu J.

Ageing Res Rev. 2021 Dec;72:101464. doi: 10.1016/j.arr.2021.101464. Epub 2021 Sep 20.

Neuroprotective Potential of Mung Bean (Vigna radiata L.) Polyphenols in Alzheimer's Disease: A Review

Xu H, Zhou Q, Liu B, Cheng KW, Chen F, Wang M.

J Agric Food Chem. 2021 Oct 6;69(39):11554-11571. doi: 10.1021/acs.jafc.1c04049. Epub 2021 Sep 22.

GLP-1 and Underlying Beneficial Actions in Alzheimer's Disease, Hypertension, and NASH

Li QX, Gao H, Guo YX, Wang BY, Hua RX, Gao L, Shang HW, Lu X, Xu JD.

Front Endocrinol (Lausanne). 2021 Sep 6;12:721198. doi: 10.3389/fendo.2021.721198. eCollection 2021.

Ferroptosis as a mechanism of neurodegeneration in Alzheimer's disease

Jakaria M, Belaidi AA, Bush AI, Ayton S.

J Neurochem. 2021 Dec;159(5):804-825. doi: 10.1111/jnc.15519. Epub 2021 Oct 9.

Alzheimer's disease neuropathology is exacerbated following traumatic brain injury. Neuroprotection by co-administration of nanowired mesenchymal stem cells and cerebrolysin with monoclonal antibodies to amyloid beta peptide

Sharma HS, Muresanu DF, Castellani RJ, Nozari A, Lafuente JV, Buzoianu AD, Sahib S, Tian ZR, Bryukhovetskiy I, Manzhulo I, Menon PK, Patnaik R, Wiklund L, Sharma A.

Prog Brain Res. 2021;265:1-97. doi: 10.1016/bs.pbr.2021.04.008. Epub 2021 Aug 12.

Deciphering the focal role of endostatin in Alzheimer's disease

Kaur D, Behl T, Chigurupati S, Sehgal A, Singh S, Sharma N, Badavath VN, Vargas-De-La-Cruz C, Bhatia S, Al-Harrasi A, Dey A, Aleya L, Bungau S.

Environ Sci Pollut Res Int. 2021 Nov;28(44):61998-62011. doi: 10.1007/s11356-021-16567-7. Epub 2021 Sep 25.

Impact of Pharmacotherapy on Insomnia in Patients with Alzheimer's Disease

Roland JP, Bliwise DL.

Drugs Aging. 2021 Nov;38(11):951-966. doi: 10.1007/s40266-021-00891-1. Epub 2021 Sep 27.

The NLRP3 Inflammasome in the Pathogenesis and Treatment of Alzheimer's Disease

Golzari-Sorkheh M, Brown CE, Weaver DF, Reed MA.

J Alzheimers Dis. 2021;84(2):579-598. doi: 10.3233/JAD-210660.

Flavonoids with Potential Anti-Amyloidogenic Effects as Therapeutic Drugs for Treating Alzheimer's Disease

Wang Q, Dong X, Zhang R, Zhao C.

J Alzheimers Dis. 2021;84(2):505-533. doi: 10.3233/JAD-210735.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias